Human umbilical cord-derived mesenchymal stem cells utilise Activin-A to suppress Interferon-gamma production by natural killer cells.
Following allogeneic hematopoietic stem cell transplantation (HSCT), interferon (IFN)-gamma levels in the recipient’s body can strongly influence the clinical outcome. Human umbilical cord-derived mesenchymal stem cells (UC-MSCs) are lucrative as biological tolerance-inducers in HSCT settings. Hence...
Main Authors: | Debanjana eChaterjee, Nicole eMarquardt, Dejene Milkessa Tufa, Tim eHatlapatka, Ralf eHass, Cornelia eKasper, Constantin evon Kaisenberg, Reinhold Ernst Schmidt, Roland eJacobs |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2014-12-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fimmu.2014.00662/full |
Similar Items
-
The orphan ligand, activin C, signals through activin receptor-like kinase 7
by: Erich J Goebel, et al.
Published: (2022-06-01) -
Acute Modulation of Synaptic Plasticity of Pyramidal Neurons by Activin in Adult Hippocampus
by: Yoshitaka eHasegawa, et al.
Published: (2014-06-01) -
The systemic activin response to pancreatic cancer: implications for effective cancer cachexia therapy
by: Xiaoling Zhong, et al.
Published: (2019-10-01) -
Activin-A up-regulates type I activin receptor mRNA levels in human immortalized extravillous trophoblast cells.
by: Leung Peter CK, et al.
Published: (2003-03-01) -
Activin signaling in the pathogenesis and therapy of neuropsychiatric diseases
by: Andrea eLink, et al.
Published: (2016-05-01)